Showing results (2121-2130 of 10,003) with videos related to
Sort By:
Pageof 1,001
Leukemia & Lymphoma|June 6, 2013
Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcomeKarin Boslooper, Robby Kibbelaar, Huib Storm, et al.Leukemia & Lymphoma|October 19, 2017
Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myelomaRaman Kumar, Rehan Khan, Nidhi Gupta, et al.Leukemia & Lymphoma|October 19, 2017
Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remissionWei-Yang Li, Ying Wang, Su-Ning Chen, et al.Leukemia & Lymphoma|February 8, 2018
ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristicsKaterina Kakosaiou, Fotios Panitsas, Aggeliki Daraki, et al.Leukemia & Lymphoma|February 9, 2018
A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemiaFiona He, Smarika Sapkota, Sarah Parker, et al.Leukemia & Lymphoma|November 23, 2017
The importance of FLT3 mutational analysis in acute myeloid leukemiaMrinal M PatnaikLeukemia & Lymphoma|November 23, 2017
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factorsSun-Hye Ko, Jung-Hee Lee, Je-Hwan Lee, et al.Leukemia & Lymphoma|November 23, 2017
Ibrutinib and idelalisib block immunophenotypic changes associated with the adhesion and activation of CLL cells in the tumor microenvironmentYandong Shen, O Giles Best, Stephen P Mulligan, et al.Leukemia & Lymphoma|November 23, 2017
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experienceKhalil Saleh, Alina Danu, Serge Koscielny, et al.Leukemia & Lymphoma|November 23, 2017
STAT3 inhibition as a therapeutic strategy for leukemiaRubashruti Kanna, Gaurav Choudhary, Nandini Ramachandra, et al.Pageof 1,001